| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |